INTRA CELLULAR THERAPIES INC's ticker is ITCI and the CUSIP is 46116X101. A total of 92 filers reported holding INTRA CELLULAR THERAPIES INC in Q2 2015. The put-call ratio across all filers is 0.54 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2016 | $30,697,000 | +83.9% | 2,034,263 | +85.7% | 0.01% | +100.0% |
| Q3 2016 | $16,691,000 | -58.8% | 1,095,218 | +5.0% | 0.00% | -66.7% |
| Q2 2016 | $40,493,000 | +50.0% | 1,043,100 | +7.4% | 0.01% | +50.0% |
| Q1 2016 | $26,992,000 | -47.0% | 970,940 | +2.6% | 0.01% | -50.0% |
| Q4 2015 | $50,910,000 | +43.4% | 946,458 | +6.7% | 0.01% | +33.3% |
| Q3 2015 | $35,507,000 | +12.1% | 886,797 | -10.6% | 0.01% | +12.5% |
| Q2 2015 | $31,688,000 | +35.8% | 991,786 | +1.5% | 0.01% | +33.3% |
| Q1 2015 | $23,329,000 | +176.1% | 976,946 | +104.1% | 0.01% | +200.0% |
| Q4 2014 | $8,450,000 | +52.1% | 478,734 | +18.1% | 0.00% | 0.0% |
| Q3 2014 | $5,557,000 | -21.9% | 405,346 | -3.9% | 0.00% | 0.0% |
| Q2 2014 | $7,115,000 | – | 421,993 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Sarissa Capital Management LP | 675,000 | $26,203,000 | 7.44% |
| EcoR1 Capital, LLC | 244,950 | $9,509,000 | 3.75% |
| Redmile Group, LLC | 971,565 | $37,716,000 | 3.60% |
| Ghost Tree Capital, LLC | 120,000 | $4,658,000 | 1.34% |
| SENZAR ASSET MANAGEMENT, LLC | 144,624 | $5,614,304,000 | 1.22% |
| GREAT POINT PARTNERS LLC | 100,000 | $3,882,000 | 1.11% |
| BB BIOTECH AG | 700,000 | $27,174,000 | 1.07% |
| Rhenman & Partners Asset Management AB | 115,000 | $4,464,000 | 0.79% |
| Lisanti Capital Growth, LLC | 12,260 | $476,000 | 0.72% |
| Rock Springs Capital Management LP | 190,000 | $7,376,000 | 0.55% |